Rational drug discovery: What can we learn from regulatory networks?

Drug Discovery Today

Volumn 7, Issue 20, 2002, Pages

  Huang, Sui ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

DATA BASE; DRUG RESEARCH; GENE ACTIVATION; GENE MAPPING; GENE SEQUENCE; GENETIC ENGINEERING; GENETIC TRAIT; GENOME ANALYSIS; GENOMICS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; MEDICAL GENETICS; MOLECULAR INTERACTION; PHENOTYPE; REVIEW;

COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; NEURAL NETWORKS (COMPUTER); PHARMACOLOGY; PHENOTYPE; PHYSICAL CHROMOSOME MAPPING; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0037108001     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02463-7     Document Type: Review

References (30)

1. Claverie J.M. Gene number. What if there are only 30,000 human genes? Science. 291:2001;1255-1257.
2. Editorial (2001) The usual suspects. Molecular drug targets 2001. Nat. Biotechnol. 19 (6) (Poster)
3. Huang S. Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. Pharmacogenomics. 2:2001;203-222.
4. Huang S., Ingber D.E. Shape-dependent control of cell growth, differentiation and apoptosis: switching between attractors in cell regulatory networks. Exp. Cell. Res. 261:2000;91-103.
5. Strohman R.C. The coming Kuhnian revolution in biology. Nat. Biotechnol. 15:1997;194-200.
6. Coffey D.S. Self-organization, complexity and chaos: the new biology for medicine. Nat. Med. 4:1998;882-885.
7. Bar-Yam, Y. (1997) Dynamics in Complex Systems (Studies in Nonlinearity), Perseus Publishing
8. Marcotte E.M. The path not taken. Nat. Biotechnol. 19:2001;626-627.
9. Tavazoie S., et al. Systematic determination of genetic network architecture. Nat. Genet. 22:1999;281-285.
10. Mewes H.W., et al. MIPS: a database for genomes and protein sequences. Nucleic Acids Res. 30:2002;31-34.
11. Costanzo M.C., et al. YPD, PombePD and WormPD: model organism volumes of the BioKnowledge library, anintegrated resource for protein information. Nucleic Acids Res. 29:2001;75-79.
12. von Mering C., et al. Comparative assessment of large-scale data sets of protein-protein interactions. Nature. 417:2002;399-403.
13. Barabasi A.-L. Linked: The New Science of Networks. 2002;Perseus Publishing.
14. D'haeseleer P., et al. Genetic network inference: from co-expression clustering to reverse engineering. Bioinformatics. 16:2000;707-726.
15. Yeung M.K., et al. Reverse engineering gene networks using singular value decomposition and robust regression. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6163-6168.
16. Fraser H.B., et al. Evolutionary rate in the protein interaction network. Science. 296:2002;750-752.
17. Jeong H., et al. Lethality and centrality in protein networks. Nature. 411:2001;41-42.
18. Strogatz S.H. Exploring complex networks. Nature. 410:2001;268-276.
19. Wagner A. Estimating coarse gene network structure from large-scale gene perturbation data. Genome Res. 12:2002;309-315.
20. Maslov S., Sneppen K. Specificity and stability in topology of protein networks. Science. 296:2002;910-913.
21. Albert R., et al. Error and Attack tolerance of complex networks. Nature. 406:2000;378-382.
22. Kauffman S.A. The origins of order. 1992;Oxford University Press.
23. Bailey J.E. Complex biology with no parameters. Nat Biotechnol. 19:2001;503-504.
24. Jelkmann W., Hellwig-Burgel T. Biology of erythropoietin. Adv. Exp. Med. Biol. 502:2001;169-187.
25. Del Valle J., Gantz I. Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273:1997;G987-G996.
26. Cody R.J. The integrated effects of angiotensin II. Am. J. Cardiol. 79:1997;9-11.
27. Yin M.J., et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80.
28. Alpert D., Vilcek J. Inhibition of IκB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells. J. Biol. Chem. 275:2000;10925-10929.
29. Vane J.R., Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47:(Suppl. 2):1998;S78-S87.
30. Wong D.T., Bymaster F.P. Dual serotonin and noradrenaline uptake inhibitor class of antidepressant potential for greater efficacy or just hype? Prog. Drug. Res. 58:2002;169-222.